Cercar
01/12/2024
Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene
van Kleef, ESB, Bouman, K, Molenaar, JPF, Küsters, B, Groothuis, JT, Olivé, M, Malfatti, E, Kamsteeg, EJ, Van Engelen, BGM, Ottenheijm, CAC, Doorduin, J, Voermans, NC. Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene. Neurology-Genetics. 2024; 10(6)DOI:10.1212/NXG.0000000000200214. PMID:39651462. IF:3.700(Q1/3D).
01/03/2026
Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease
Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).
01/01/2026
Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement
Torchia, E, Lucchini, M, Verdu-Diaz, J, Bortolani, S, Ravera, B, Carlomagno, V, Cicia, A, Bernardo, D, Monforte, M, Rehmann, R, Kley, RA, Sabatelli, M, Díaz-Manera, J, Ricci, E, Mirabella, M, Tasca, G. Muscle Imaging in Inclusion Body Myositis: Refinement of MRI Criteria and Insights Into Upper Body Involvement. Journal of Cachexia Sarcopenia and Muscle. 2026; 17(1)DOI:10.1002/jcsm.70173. PMID:41549703. IF:9.100(Q1/1D).
01/03/2026
Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial
Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).
01/03/2026
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain
De Pedro, S, Presa, M, Gamez, J, Fernández, FJG, Querol, L. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain. Pharmacoeconomics-Open. 2026; 10(2)DOI:10.1007/s41669-025-00633-8. PMID:41528376. IF:(Q/D).
01/05/2024
Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis
Costas-Carrera, A, Verdolini, N, Garcia-Rizo, C, Mezquida, G, Janssen, J, Valli, I, Corripio, I, Sanchez-Torres, AM, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Rapado-Castro, M, Vieta, E, de la Serna, H, Mane, A, Roldan, A, Crossley, N, Penades, R, Cuesta, MJ, Parellada, M, Bernardo, M. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis. PSYCHOLOGICAL MEDICINE. 2024; DOI:10.1017/S0033291723003185. PMID:38014924. IF:5.500(Q1/1D).
01/02/2024
Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Argyelan M, Deng ZD, Ousdal OT, Oltedal L, Angulo B, Baradits M, Spitzberg AJ, Kessler U, Sartorius A, Dols A, Narr KL, Espinoza R, van Waarde JA, Tendolkar I, van Eijndhoven P, van Wingen GA, Takamiya A, Kishimoto T, Jorgensen MB, Jorgensen A, Paulson OB, Yrondi A, Péran P, Soriano-Mas C, Cardoner N, Cano M, van Diermen L, Schrijvers D, Belge JB, Emsell L, Bouckaert F, Vandenbulcke M, Kiebs M, Hurlemann R, Mulders PC, Redlich R, Dannlowski U, Kavakbasi E, Kritzer MD, Ellard KK, Camprodon JA, Petrides G, Malhotra AK, Abbott CC. Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.. MOLECULAR PSYCHIATRY. 2024; 29(2)DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:(Q/D).
01/01/2024
Patterns of Use and Withdrawal Syndrome in Dual Cannabis andTobacco Users (DuCATA_GAM-CAT):Protocol for a MixedMethods Study
Saura, J, Feliu, A, Enriquez-Mestre, M, Fu, M, Ballbe, M, Castellano, Y, Pla, M, Rosa, N, Radeva, P, Maestre-Gonzalez, E, Cabezas, C, Colom, J, Suelves, JM, Mondon, S, Barrio, P, Andreu, M, Raich, A, Bernabeu, J, Vilaplana, J, Tutusaus, XR, Guydish, J, Fernandez, E, Martinez, C. Patterns of Use and Withdrawal Syndrome in Dual Cannabis andTobacco Users (DuCATA_GAM-CAT):Protocol for a MixedMethods Study. Jmir Research Protocols. 2024; 13DOI:10.2196/58335. PMID:39298750. IF:(Q/D).